dc.creatorBertrán, M.
dc.creatorTagle, F. P.
dc.creatorIrarrázaval Domínguez, Matías
dc.date.accessioned2018-08-03T20:15:11Z
dc.date.available2018-08-03T20:15:11Z
dc.date.created2018-08-03T20:15:11Z
dc.date.issued2018
dc.identifierNeurología. 2018;33(2):121-128
dc.identifier10.1016/j.nrl.2015.07.007
dc.identifierhttps://repositorio.uchile.cl/handle/2250/150663
dc.description.abstractIntroduction: The 22q11.2 deletion syndrome is a genetic disorder with variable clinical manifestations. It affects one out of 5950 neonates and has an autosomal dominant inheritance pattern. The aim of this article is to review its psychiatric manifestations and any underlying genetic alterations. Methods: We reviewed the scientific literature available as of October 2014 in the LILACS and Medline databases. Results: Sixty per cent of these patients fulfilled diagnostic criteria for a mental disorder at some point in their lives, referring to psychotic disorders, attention deficit hyperactivity disorder, mood disorders, anxiety disorders, and autism spectrum disorders. Specific genes, such as COMT and PRODH, have been linked to these psychiatric manifestations. Conclusions: It is necessary to raise awareness among all health care professionals so that they understand the relevance of these manifestations, are able to anticipate them, and can provide appropriate information to patients and family members.
dc.languageen
dc.publisherElsevier
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceNeurología
dc.subject22q11.2 deletion syndrome
dc.subjectPsychiatric comorbidity
dc.subjectGenetics
dc.titlePsychiatric manifestations of 22q11.2 deletion syndrome: a literature review
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución